List of Studies ( Metabolite:PC 16:0/9:0(CHO))
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004287 | AN007127 | Lipidomic profiling of PILRAKO xMG in xenotransplant model after mouse microglia(mMg) depletion | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004230 | AN007041 | Effect of ATV:4D9 on Microglial Metabolism and FDG levels in mKate-TREM2/APP mouse model | Microglia | Mouse | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004206 | AN006995 | Lipidomic Profiling of Sorted Microglia in GPR34-KO/APP-KI Mice Across 4, 8, 16, and 24 Months | Glial cells | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004205 | AN006992 | Lipidomic/Metabolomic Characterization of GPR34 KO, WT, TREM2 KO, and GPR34/TREM2 dKO iPSC1-derived microglia | Glial cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006908 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Metabolic disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006908 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006714 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006714 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST003737 | AN006134 | PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST003501 | AN005746 | TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism | Microglia | Mouse | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | Walter and Eliza Hall Institute of Medical Research | LC-MS |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mouse | Diabetes | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001795 | AN002915 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000608 | AN000929 | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies | Blood | Human | Pacific Northwest National Laboratory | GC-MS/LC-MS | |
| ST000445 | AN000696 | Follicular fluid lipidomics reveals lipid alterations by LH addition during IVF cycles | Follicular fluid | Human | Universidade Federal de Sao Paulo | LC-MS | |
| ST000414 | AN000655 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |